» Articles » PMID: 38902294

Prognostic Scoring System Based on Indicators Reflecting the Tumor Glandular Differentiation and Microenvironment for Patients with Colorectal Cancer

Abstract

Prognostic stratification is an urgent concern for patients with colorectal cancer (CRC). The desmoplastic reaction (DR) is speculated to mirror the tumor microenvironment. DR types are considered independent prognostic indicators in CRC, but have not been incorporated in previous prognostic nomograms. We aimed to assess the prognostic significance of a novel approach incorporating histopathological indicators reflecting tumor glandular differentiation and microenvironment. We evaluated 329 consecutive patients with CRC who underwent surgical resection at Kansai Medical University. Histological glandular differentiation was scored as 2 (0 point), 3 (1 point), or 4 (2 points). Tumor buddings (TBs) were classified as TB1 (0 point), TB2 (1 point), or TB3 (2 points). pT1 or 2 was considered as 0 point, pT3 or 4 + DR non-immature type as 1 point, and pT3 or 4 + DR immature type as 2 points. Lymph node metastasis was classified as pN0 (0 point), pN1 (1 point), or pN2 (2 points). The preoperative carcinoembryonic antigen levels were categorized as < 5.0 ng/mL (0 point) and ≧5.0 (1 point). Considering these factors, the following D&M (tumor differentiation and microenvironment) scoring system was applied: I (0-2 points), II (3-4 points), III (5-6 points), and IV (7-9 points). Kaplan-Meier curves showed significant differences in disease-specific survival and recurrence-free survival among the assigned scores, highlighting their enhanced utility compared with the American Joint Committee on Cancer 8th edition staging system. The D&M scoring system was valuable as the initial prognostic nomogram, including DR.

Citing Articles

Relationship of Desmoplastic Reaction and Tumour Budding in Primary and Lung Metastatic Lesions of Colorectal Cancer and Their Prognostic Significance.

Kobayashi T, Ishida M, Matsui H, Uehara H, I S, Yamada N Cancers (Basel). 2025; 17(4).

PMID: 40002175 PMC: 11852406. DOI: 10.3390/cancers17040583.

References
1.
Kobayashi T, Ishida M, Miki H, Hatta M, Hamada M, Hirose Y . Significance of desmoplastic reactions on tumor deposits in patients with colorectal cancer. Oncol Lett. 2022; 25(1):1. PMC: 9677517. DOI: 10.3892/ol.2022.13587. View

2.
Ueno H, Ishiguro M, Nakatani E, Ishikawa T, Uetake H, Murotani K . Prognostic value of desmoplastic reaction characterisation in stage II colon cancer: prospective validation in a Phase 3 study (SACURA Trial). Br J Cancer. 2021; 124(6):1088-1097. PMC: 7960987. DOI: 10.1038/s41416-020-01222-8. View

3.
Weiser M, Hsu M, Bauer P, Chapman Jr W, Gonzalez I, Chatterjee D . Clinical Calculator Based on Molecular and Clinicopathologic Characteristics Predicts Recurrence Following Resection of Stage I-III Colon Cancer. J Clin Oncol. 2021; 39(8):911-919. PMC: 8189618. DOI: 10.1200/JCO.20.02553. View

4.
Konishi T, Shimada Y, Hsu M, Wei I, Pappou E, Smith J . Contemporary Validation of a Nomogram Predicting Colon Cancer Recurrence, Revealing All-Stage Improved Outcomes. JNCI Cancer Spectr. 2019; 3(2):pkz015. PMC: 6512350. DOI: 10.1093/jncics/pkz015. View

5.
Kosaka H, Ishida M, Ueno M, Komeda K, Hokutou D, Iida H . Tumor budding may be a promising prognostic indicator in intrahepatic cholangiocarcinoma: A multicenter retrospective study. Ann Gastroenterol Surg. 2023; 7(1):138-146. PMC: 9831894. DOI: 10.1002/ags3.12605. View